The present validation study confirmed that the genes for the MT1F, MT1X, MT1M, MT1E, and MT2A isoforms exhibit a statistically significant alteration of expression in Down’s syndrome patients with active periodontal disease and implant failure. This evidence concerns the gene MT1M and Down syndrome.